.jpeg)
The Difference Between Ponatinib and Platinib
Ponatinib and palbociclib are two different drugs used for different treatment purposes. Ponatinib is a tyrosine kinase inhibitor commonly used to treat chronic myelogenous leukemia (CML) and newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It prevents the growth and spread of abnormal cells by inhibiting the activity of the BCR-ABL fusion protein. It is not suitable for and is not recommended for the treatment of newly diagnosed CP-CML. Platinib is a CDK4/6 inhibitor used to treat breast cancer. It inhibits the proliferation of cancer cells by blocking CDK4 and CDK6 activity in the cell cycle.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
